X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-ipsens-rare-bone-disorder-drug-2023-08-16/
https://www.reuters.com/business/healthcare-pharmaceuticals/ipsen-says-european-commission-rejects-marketing-authorization-bone-disorder-2023-07-19/
https://endpts.com/fda-adcomm-votes-in-favor-of-ipsens-fibrodysplasia-drug/
https://www.globenewswire.com/news-release/2023/06/29/2696672/0/en/Ipsen-announces-positive-outcome-of-FDA-Advisory-Committee-on-investigational-palovarotene-for-fibrodysplasia-ossificans-progressiva.html
https://endpts.com/fda-reviewers-on-ipsens-potential-fibrodysplasia-drug-post-hoc-analysis-may-be-enough/
https://www.globenewswire.com/news-release/2023/05/26/2677082/0/en/Ipsen-receives-CHMP-negative-opinion-following-re-examination-of-potential-first-FOP-treatment-in-the-E-U.html
https://www.businesswire.com/news/home/20230126005858/en/Ipsen-Receives-CHMP-Negative-Opinion-for-Palovarotene-as-a-Treatment-for-Fibrodysplasia-Ossificans-Progressiva-in-E.U
https://www.ipsen.com/press-releases/ipsen-receives-complete-response-letter-for-an-investigational-treatment-for-fop/
https://pharmaphorum.com/news/ipsen-faces-yet-another-delay-for-rare-disease-drug-in-us/
https://endpts.com/trick-or-treat-fda-plans-halloween-adcomm-for-ipsens-second-chance-at-rare-disease-drug/
https://endpts.com/a-1b-plus-drug-stumbles-into-another-big-phiii-setback-as-fda-hold-remains-in-effect-for-ipsen/
https://www.fiercebiotech.com/biotech/fda-hits-ipsen-s-1b-drug-clinical-hold-over-safety-signal
https://www.fiercebiotech.com/biotech/ipsen-bags-blueprint-drug-to-move-deeper-into-ultra-rare-disease
http://investor.clementiapharma.com/news-releases/news-release-details/ipsen-acquire-clementia-pharmaceuticals-significantly-boost-rare
https://www.biocentury.com/bc-extra/financial-news/2018-10-30/clear-fda-path-clementia-raises-702m
Market Place
Share 
